USPTO serial 79097760
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas W. Brooke
Thomas W. Brooke Holland & Knight LLP2099 Pennsylvania Avenue, NWSuite 100WASHINGTON, DC 20006| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cancer, central nervous system disorder, hormonal disorder, metabolic disorder, immunologic disorder, cardiovascular system disorder, infection, pain, addiction, ophthalmological disorder, gynecological disorder, dermatological disorder; veterinary preparations for the treatment of animal disease, in the nature of cancer, central nervous system disorder, hormonal disorder, metabolic disorder, immunologic disorder, cardiovascular system disorder, infection, pain, addiction, ophthalmological disorder, gynecological disorder, dermatological disorder; sanitary preparations for medical purposes, namely, alkaline solution, chloride, tensioactive substance, iodine; Dietary food supplements, namely, protein supplements, infant formulas, preparation of herbal origin to be used for slimness, cleansing digestion, circulation and relaxation, vitamins, minerals, lecithin, meal replacement in the form of bars, drinks and capsules; Disinfectants pertaining to the pharmaceutical sector, namely, alkaline solution, chloride, tensioactive substance, iodine for hygienic purposes | SECTION 71 - CANCELLED | — |
| 042 | Research and development of new technologies in the medical and pharmaceutical fields; research and development in the field of galenic innovation; research and development in the field of medical solutions; medical and clinical studies, namely, scientific research services for medical purposes; research and development for others in the medical and pharmaceutical fields; engineering in the medical and pharmaceutical fields; chemical research; chemical analysis | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 23, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 27, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 5, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 16, 2023 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Oct 16, 2023 | INPC | INVALIDATION PROCESSED | — |
| Oct 10, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 10, 2023 | C71T | CANCELLED SECTION 71 | — |
| Jun 3, 2021 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| May 15, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 12, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 8, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 13, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 14, 2018 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILED | — |
| Aug 14, 2018 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Aug 10, 2018 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 24, 2018 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Mar 19, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 26, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 26, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 24, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 24, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 8, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 18, 2012 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 4, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 4, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 14, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 13, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 13, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2012 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 16, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 16, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 16, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 14, 2011 | ALIE | ASSIGNED TO LIE | — |
| Dec 8, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 20, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 3, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 3, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 3, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 2, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 28, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 24, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 23, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |